BRIEF published on 05/12/2026 at 10:10, 4 months ago Scantox Launches Cloud-Based Mutagenesis App for DuplexSeq™ Bioinformatics Cloud-based Mutagenesis Scantox DuplexSeq™
BRIEF published on 05/12/2026 at 10:10, 4 months ago Scantox lance une application de mutagénèse basée sur le cloud pour DuplexSeq™ Bioinformatique Basé Sur Le Cloud Mutagenèse Scantox DuplexSeq™
PRESS RELEASE published on 05/12/2026 at 10:05, 4 months ago Scantox Upgrades DuplexSeq™ Bioinformatics with Cloud-Based Mutagenesis App Scantox upgrades DuplexSeq™ bioinformatics with cloud-based Mutagenesis App, offering error-corrected sequencing on a scalable platform Bioinformatics Cloud-based DuplexSeq Mutagenesis Scantox
BRIEF published on 03/31/2026 at 10:10, 5 months 12 days ago Gentronix Joins Scantox Brand Amid Expansion Efforts Mergers & Acquisitions Industry Integration Scantox Group Genomic Safety Genetic Toxicology
BRIEF published on 03/31/2026 at 10:10, 5 months 12 days ago Gentronix rejoint la marque Scantox dans le cadre de ses efforts d'expansion Fusions Et Acquisitions Intégration Industrielle Groupe Scantox Sécurité Génomique Toxicologie Génétique
PRESS RELEASE published on 03/31/2026 at 10:05, 5 months 12 days ago Gentronix Now Operating Under the Scantox Brand Scantox Group announces Gentronix now operates under the Scantox brand as Scantox Manchester, offering integrated genetic toxicology and genomic safety services Acquisition Scantox Group Genomic Safety Genetic Toxicology Gentronix
BRIEF published on 02/26/2026 at 10:15, 6 months 14 days ago Scantox Group Acquires DuplexSeq™ Genomics Safety Business Scantox Group DuplexSeq Genomic Safety Mutagenesis TwinStrand Biosciences
BRIEF published on 02/26/2026 at 10:15, 6 months 14 days ago Le groupe Scantox acquiert l'activité de sécurité génomique DuplexSeq™ DuplexSeq TwinStrand Biosciences Groupe Scantox Sécurité Génomique Mutagenèse
PRESS RELEASE published on 02/26/2026 at 10:10, 6 months 14 days ago Scantox Acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences Scantox Group acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences, enhancing mutagenesis testing services globally Acquisition Scantox Group DuplexSeq Genomics Safety Mutagenesis Testing
Published on 09/12/2026 at 02:35, 1 day 4 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 8 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 10 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 14 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 13 hours 34 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 23 hours 54 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 9 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 9 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 11 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 11 hours ago Availability of the 2026 Interim Financial Report
